Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

NCT03813407 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03813407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03813407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Recruiting
Start date
April 2, 2019
Completion date
February 21, 2030
Enrollment
140 (estimated)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalaemia